Prosecution Insights
Last updated: October 27, 2026

Sagar S Patel, USPTO Patent Examiner

Listed by the USPTO as PATEL, SAGAR S

Tech Center 1600 • Art Units: 1626 1654

This examiner grants 76% of resolved cases

Analysis

PATEL, SAGAR S has 478 resolved cases in tech center 1600 and art unit 1626. The profile reports a 75.7% allowance rate, a 34.9% interview lift, and a median of 934 days to allowance. The positive interview measure supports considering direct examiner communication as a meaningful part of prosecution planning, while the allowance rate calls for continued attention to claim scope.

Novartis AG, Merck Sharp & Dohme LLC, and Corteva Agriscience LLC are the listed companies. The listed firms are COOLEY LLP, CANTOR COLBURN LLP - UPL LIMITED, and CKC & Partners Co., LLC. Practitioners can use interviews to clarify technical and patentability issues, with written amendments preserving a durable prosecution record.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

75.7%
Allow Rate
+15.7% vs TC avg
505
Total Applications
+34.9%
Interview Lift
934
Avg Prosecution Days
Based on 478 resolved cases, 2023–2026

Rejection Statute Breakdown

1.5%
§101 Eligibility
20.1%
§102 Novelty
38.0%
§103 Obviousness
24.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17350374 PESTICIDALLY ACTIVE HETEROCYCLIC DERIVATIVES WITH SULPHUR CONTAINING SUBSTITUENTS Final Rejection SYNGENTA PARTICIPATIONS AG
17314196 COMPOUNDS HAVING ANTIBACTERIAL ACTIVITY AND METHODS OF USE Non-Final OA The Trustees of Princeton University
18676998 COMPOSITION COMPRISING PIP4K2C INHIBITOR AS ACTIVE INGREDIENT FOR TREATMENT OF CANCER Non-Final OA GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY
18593673 ISOXAZOLE DERIVATIVE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND USE THEREOF Non-Final OA INDUSTRY-UNIVERSITY COOPERATION FOUNDATION HANYANG UNIVERSITY ERICA CAMPUS
18403664 METHODS OF TREATING NEURODEGENERATIVE DISEASES OR CONDITIONS Non-Final OA The Salk Institute for Biological Studies
18711979 METHOD OF IMPROVING PLANT GROWTH Non-Final OA UPL LIMITED

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Sagar S Patel's allowance rate?

75.7% of resolved applications examined by Sagar S Patel were allowed (478 resolved cases), compared with 54.9% across Art Unit 1626 over the last five years.

Does an interview help with examiner Sagar S Patel?

This examiner's interview lift is +34.9 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Sagar S Patel take to allow a patent?

Applications allowed by Sagar S Patel took 934 days on average from filing to allowance.

Which art unit does examiner Sagar S Patel work in?

Sagar S Patel examines applications in Art Unit 1626 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month